Publications

Eradicating Pseudomonas Persistence in Adult Patients With Cystic Fibrosis With A New Algorithm Of Antibiotic Selection.

CHEST Journal (2021)

Evaluation of a New Culture-Based AtbFinder Test-System Employing a Novel Nutrient Medium for the Selection of Optimal Antibiotics for Critically Ill Patients with Polymicrobial Infections within 4 h

Microorganisms (2021)

Bacterial Extracellular DNA Promotes β-Amyloid Aggregation

Microorganisms (2021)

Neutrophil extracellular traps blockade in combination with PD-1 inhibition in treatment of colorectal cancer metastasis.

Journal of Clinical Oncology (2020)

AAV‐mediated gene transfer of DNase I in the liver of mice with colorectal cancer reduces liver metastasis and restores local innate and adaptive immune response

Molecular Oncology (2020)

“Bacterial DNA promotes tau and beta-amyloid aggregation and is suggested as a novel therapeutic target for Alzheimer’s disease” The Lancet Summit. December 14-16, 2021

New York, NY (December 16, 2022) – A New-York city-based Human Microbiology Institute presented “Bacterial DNA promotes tau and beta-amyloid aggregation and is suggested as a novel therapeutic target for Alzheimer’s disease” at the Lancet Summit: Presymptomatic Prevention and Treatment of Neurodegenerative Diseases.

SARS-CoV-2 Prion-Like Domains in Spike Proteins Enable Higher Affinity to ACE2

TBDL(2020)

Bacterial DNA promotes Tau aggregation

Scientific Reports (2020)

A new biological definition of life

Biomolecular Concepts (2020)

Bacterial DNA induces the formation of heat-resistant disease-associated proteins in human plasma

Scientific Reports (2019)